Gregg Semenza Nobel Prize Speaker and discoverer of HIF-1 at Johns Hopkins

Gregg Semenza

2019 Nobel Laureate in Physiology or Medicine | Discoverer of HIF-1 | C. Michael Armstrong Professor, Johns Hopkins University

Gregg Semenza helped answer one of biology's oldest questions, how cells sense and respond to oxygen, and shared the 2019 Nobel Prize in Medicine for identifying the master switch HIF-1. A professor at Johns Hopkins, he brings to the stage both scientific authority and a gift for making complex biology feel immediate and human. Audiences leave understanding not only the science, but why it matters to every living cell.

Want to book Gregg Semenza as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:

    Gregg Semenza biography

    Gregg Semenza is the scientist who helped answer one of biology’s most fundamental questions: how do the cells of the body sense when oxygen is running low, and how do they respond? Nobel Prize speaker Gregg Semenza identified hypoxia-inducible factor 1, known as HIF-1, a molecular switch so central to life that it influences processes ranging from embryonic development to the growth of tumors and the production of red blood cells. For this work he shared the 2019 Nobel Prize in Physiology or Medicine with William Kaelin Jr. and Sir Peter Ratcliffe.

    Semenza is the C. Michael Armstrong Professor of Genetic Medicine at the Johns Hopkins University School of Medicine, where he founded and directs the vascular program within the Institute for Cell Engineering. He trained at Harvard, earned his MD-PhD at the University of Pennsylvania, and completed further training at Duke before joining Johns Hopkins, where he has built his research career for more than three decades.

    How the Body Senses Oxygen

    The discovery began with a deceptively simple puzzle: why does the body produce more red blood cells when oxygen levels fall? Semenza traced the answer to HIF-1, a protein complex that acts as a master regulator of the cellular response to low oxygen. Under normal conditions the HIF-1 alpha subunit is rapidly broken down; when oxygen drops, it stabilizes and switches on programs of gene activity that stimulate new blood vessel formation, adjust metabolism, and help cells adapt and survive. Because this mechanism operates in virtually every cell, its relevance reaches across the whole of modern medicine.

    The science of oxygen sensing has since moved from the laboratory toward the clinic. A class of drugs known as HIF stabilizers, including roxadustat, has been approved in several countries to treat anemia in chronic kidney disease, offering an oral alternative to injectable therapies, while researchers continue to explore how targeting the same pathway might help in cancer and other conditions. The field Semenza helped open remains one of the most active areas of biomedical research.

    As a speaker, Gregg Semenza offers audiences something rare: the chance to hear a Nobel laureate explain, in clear and vivid terms, how patiently following a single scientific question can reshape our understanding of medicine. He speaks on the process of discovery as much as the result, and his talks resonate with audiences in healthcare, biotech, and any organization that treats curiosity as a driver of breakthrough. Discover more Nobel Prize speakers to bring that perspective to your stage.

    Gregg Semenza Speaking Videos

    Gregg Semenza virtual keynote speech
    Nobel Lecture: Gregg L. Semenza, Nobel Prize in Physiology or Medicine 2019

    Gregg Semenza Keynote Topics

    The story of HIF-1 is one of the great detective stories of modern science, a decades-long pursuit that began with a question about red blood cells and ended with a Nobel Prize. Semenza walks audiences through the discovery process: what was known, what was inexplicable, which experiments led where, and what it felt like to realize the molecular switch he had found was active in every cell of the body. Accessible, fascinating, and a masterclass in what patient, rigorous science can achieve.

    Tumors are not passive masses; they are adaptive systems that exploit the body's own machinery to survive. Semenza explains how cancer cells hijack the oxygen-sensing response to grow blood vessels, fuel their metabolism, and spread, and why the same pathway has become such a compelling target for a new generation of therapies. A clear scientific briefing and a view of the near future, delivered by the scientist who helped open the field.

    What does it actually take to make a landmark discovery? Semenza's answer is not about genius but about the daily discipline of following a question wherever it leads, tolerating failure, building a team, and having the courage to use whatever method a problem demands. This keynote is an inspiring and practical exploration of what scientific leadership and creative persistence look like across a full career.

    The path from a laboratory observation to an approved treatment is long, uncertain, and expensive, and it begins with scientists asking questions that have no obvious commercial value. Semenza uses the story of oxygen sensing as a case study in how foundational biology, pursued for its own sake, ultimately reshapes medicine. Essential for biotech, pharma, and healthcare audiences thinking about research investment, innovation pipelines, and the cultures that produce breakthroughs.

    FAQs on Booking Gregg Semenza

    Why Gregg Semenza?

    Booking Gregg Semenza brings a genuine Nobel laureate to your event, the scientist whose laboratory work identified HIF-1 and helped explain how every cell in the body senses and adapts to oxygen. It is a discovery that reshaped the understanding of cancer biology and opened new directions in treating conditions from anemia to heart disease. At the podium he pairs the rigor of a working scientist with a real desire for his audience to understand why the science matters. For healthcare and biotech companies, medical conferences, and universities, he is an exceptional choice. Contact Aurum Speakers Bureau to check his availability.

    What did Gregg Semenza win the Nobel Prize for?

    Gregg Semenza shared the 2019 Nobel Prize in Physiology or Medicine with William Kaelin Jr. and Sir Peter Ratcliffe for discoveries of how cells sense and adapt to changes in oxygen availability. Semenza's contribution was identifying HIF-1, hypoxia-inducible factor 1, a protein complex that acts as a master regulator of the response to low oxygen. When oxygen falls, HIF-1 switches on genes involved in red blood cell production, blood vessel growth, and metabolic adaptation, a mechanism active in nearly every cell of the body.

    What is HIF-1 and why does it matter for cancer?

    HIF-1, hypoxia-inducible factor 1, is a protein that works as a cellular oxygen sensor. When a cell's oxygen supply drops, as it does in the poorly supplied cores of tumors, HIF-1 activates genes that help the cell survive by growing new blood vessels, shifting metabolism, and resisting stress. Because tumors exploit this same response to grow and spread, the pathway has become an important target for researchers developing new cancer therapies, and drugs that act on the oxygen-sensing pathway are already in clinical use for other conditions.

    What topics does Nobel Prize speaker Gregg Semenza cover?

    Gregg Semenza speaks on the discovery of HIF-1 and how cells sense oxygen, the role of hypoxia in cancer, the long path from basic research to new treatments, and what it takes to sustain a scientific career built on curiosity and persistence. His keynotes suit healthcare and life-sciences conferences, pharmaceutical and biotech audiences, medical schools, and leadership events focused on the link between fundamental science and real-world impact. Contact Aurum Speakers Bureau to discuss formats and availability.

    How to book Gregg Semenza as a keynote speaker?

    Aurum Speakers Bureau can help you book Gregg Semenza as a speaker for your next event, conference, or board meeting. Simply fill out our contact form to inquire about Gregg Semenza's availability for a speaking engagement. One of our booking agents will respond to your request immediately and contact the speaker to let them know you want to hire them. We will assist you with obtaining speaking fees, booking information, and confirming availability for Gregg Semenza or any other top keynote speaker or celebrity of your choice.

    How much is Gregg Semenza speaking fee?

    Gregg Semenza speaking fees are determined by several factors, including the event's date, whether it's a virtual or in-person event, the duration, format, preparation required for their speech, and more. The same applies to the cost to hire any other top expert speakers and celebrities. The Speaker Fee Range listed on our website is simply a guideline and is subject to change without notice. If you would like to hire Gregg Semenza to deliver a keynote speech for your event, please fill out the contact form or email us at info@aurumbureau.com with as much detail as possible. One of our experienced agents will get in touch with you and let you know exactly how much it will cost to book Gregg Semenza.

    How can I contact Gregg Semenza?

    We only work with Gregg Semenza on paid speaking engagements. Aurum Speakers Bureau can assist you in booking Gregg Semenza and will handle all negotiations, contracts, and logistics associated with having Gregg Semenza speak at your event. We will be your sole point of contact throughout the process. Get in touch with Aurum Speakers Bureau today, and we will reach out to any motivational speaker or celebrity you want to enquire about speaking at your event. If you wish to contact Gregg Semenza for any other reason, we will be unable to assist you as we are not authorized to provide personal contact information.

    Can I book Gregg Semenza for a virtual keynote?

    Yes, Gregg Semenza is available for virtual keynotes and webinars. To book Gregg Semenza for a virtual event, please complete the contact form or send us an email to inquire about the special fees for virtual engagements.